Download Frauenshuh Cancer Center 2014 Annual Report

2014 Annual Report
Our mission is to
improve the survival
and quality of life of
those we serve.
A note to our colleagues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2014 highlights. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2014 screening and prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Team spotlight. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2014 awards and achievements. . . . . . . . . . . . . . . . . . . . . . . . . . 10
Oncology registry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Oncology research review. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Donors for 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Cancer committee. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
A note to our colleagues
Dear colleagues,
Cancer is a complex and continually evolving disease. At Park Nicollet Frauenshuh Cancer Center, we
believe that fostering research is essential to advancing an understanding of this disease. We look forward
to the day when, through research, cancer can be prevented and cured.
Our two feature articles, on pages 13 and 16, outline our research initiatives undertaken in 2014 – as well as
our ongoing and future commitment to research. Dylan Zylla, MD, our medical oncologist and co-medical
director of oncology research at Park Nicollet, is committed to finding better ways to relieve cancer pain
and other burdensome symptoms.
Our many events are also important in helping to raise awareness and support for cancer research,
prevention and patient care initiatives.
To that end, Frauenshuh Cancer Center and Park Nicollet Dermatology collaborated to host a free
skin cancer screening event for the community on May 17. We were pleased to serve 103 participants.
Eight percent of those screened were identified as having non-melanoma skin cancer; 40 percent were
recommended for a follow-up appointment because of suspicious skin issues.
Park Nicollet’s Jane Brattain Breast Center and Park Nicollet Foundation continue their Be Pink initiative
to support and promote breast health, early screening and breast cancer detection for women in the Twin
Cities. Because of a strong Be Pink campaign in October, screening mammography volumes increased by
10 percent that month. Diagnostic screenings increased more than 25 percent.
We are extremely grateful for the many gifts from our donors and supporters. These critical funds are used
to advance research and improve care to our patients. In 2014, through donor generosity and the Park
Nicollet Foundation, we have been able to offer patients integrative healing care, including music therapy,
education and critical support services. Gifts supporting these important programs at Frauenshuh Cancer
Center and the Jane Brattain Breast Center are listed on pages 22-27.
If you would like more information about our comprehensive cancer services or have questions about this
report, please contact us at 952-993-3248.
Sincerely,
Mark A. Wilkowske, MD,
Medical Director,
Oncology Services
4
Laura J. Holasek,
Administrative Director,
Oncology Services
Park Nicollet Frauenshuh cancer center | 2014 annual report
Mark A. Wilkowske, MD, is medical director of oncology
services for Frauenshuh Cancer Center. Dr. Wilkowske
received his bachelor’s degree and medical degree from the
University of Minnesota. From 1988 to 1994, he received
postgraduate training in internal medicine and hematologyoncology. He is board-certified by the American Board of
Internal Medicine, Subspecialty Board of Medical Oncology
and Subspecialty Board of Hematology. His professional
associations include American College of Physicians and
American Medical Association. He is past president of the
Minnesota Society of Clinical Oncology. Dr. Wilkowske
has served on Park Nicollet’s Board of Directors, the
Park Nicollet Foundation Board of Directors and the Park
Nicollet Executive Medical Council.
Laura Holasek, is the administrative director of Frauenshuh
Cancer Center. Holasek earned her bachelor’s degree in
health care administration from the University of WisconsinEau Claire. She has been with Park Nicollet Methodist
Hospital since 2000, working as radiation oncology manager
in charge of Radiation Oncology before being named
administrative director of the cancer center in January of
2011. She has focused experience in Lean methodologies
and is Lean certified. On Jan. 1, 2014, Holasek assumed
the role of oncology system director for the combined
HealthPartners and Park Nicollet organization.
Park Nicollet Frauenshuh cancer center | 2014 annual report
5
Frauenshuh Cancer Center
2014 highlights
Nature
increases
health and
improves
well-being.
QOPI Certification Renewal
Following a successful survey in June 2014, Frauenshuh Cancer Center achieved another three-year
certification from the American Society of Clinical Oncology (ASCO) Quality Oncology Practice Initiative
(QOPI). This program provides tools for measurement, benchmarking and quality improvement of more
than 80 quality measures. In the spring of 2014, there were only 244 QOPI-certified programs across
the country and only four in Minnesota. ASCO’s Quality Oncology Practice Initiative is an oncologist-led,
quality assessment program designed to promote excellence in cancer care.
Commission on Cancer Survey
The Frauenshuh Cancer Center received an Outstanding Achievement Award from the American College
of Surgeons’ Commission on Cancer for achieving excellence in providing care to cancer patients. This is
the highest commendation awarded by the commission and requires a review of the scope, operations and
activity of the cancer center as well as compliance with 36 standards. As part of the successful Nov. 2014
survey, the commission also renewed the center’s three-year accreditation.
Survivorship Celebration
In partnership with Park Nicollet Foundation, National Cancer Survivors Day was held Saturday, June
28, 2014 at the Minnesota Landscape Arboretum. “On the Wings of Hope” featured cancer patient Ruth
Bachman as the keynote speaker. Bachman was diagnosed with soft tissue sarcoma in 2003. “I have learned
that with patience and persistence, I can do anything I want to do,” she told the attendees. The event also
included the release of butterflies in Sandra’s Garden of Hope.
6
Park Nicollet Frauenshuh cancer center | 2014 annual report
Nature Heals Day
A connection to nature is vital to human health and well-being. Those interested in learning about the
healing power of nature, and understanding more about how nature increases health and improves
well-being, were able to participate in Nature Heals Day on Aug. 16, 2014. The event was held at the
Minnesota Landscape Arboretum.
Marathons of Hope
Event participants
Marathons of Hope is a certified 5K/10K, and walk, run, bike
or blade around Lake Calhoun to raise funds for Park Nicollet
Frauenshuh Cancer Center. This event was held on Sept. 6, 2014,
and included more than 300 participants who raised $54,897 for
cancer patients’ support and education programs.
Minnesota Density Reporting Law
The Minnesota Density Reporting Law Chapter 291 was approved in May 2014 and implemented Aug.
1. The law requires mammography providers, including Jane Brattain Breast Center, to notify women
categorized as having dense breast tissue about their condition. Dense breasts have more fibrous or
glandular tissue and not as much fat; women with dense breasts have a slightly higher risk of breast
cancer. Approximately 40 percent of women fall into this category.
Oncology Symposium at Park Nicollet
Care providers hosted an education day for staff at Park Nicollet Clinic on April 5, 2014. The event’s
focus was on cancer care and treatments and was sponsored by the HealthPartners/Park Nicollet
Oncology/Hematology Program. Mark A. Wilkowske, MD, medical director, presented information on
alternative therapies related to cancer care. Discussing uncommon reactions to chemotherapy was
Randy Hurley, MD, medical director, HealthPartners and Regions Hospital Cancer Care Center.
Kaizen Event at Burnsville and Maple Grove
A new standardized cancer infusion scheduling process was created this year to maximize efficiency and
increase patient and staff satisfaction at our Burnsville and Maple Grove locations. The process indicates
when infusion nurses are available and when treatment chairs are available.
Oncology Education Day in Wisconsin
Daniel Anderson, MD, presented “Cancer-Related Fatigue” at the Cancer Center of Western Wisconsin’s
Oncology Education Day in New Richmond on Nov. 15, 2014. The event’s main focus was Ancillary
Care and Symptom Management; it was co-sponsored by the Cancer Center of Western Wisconsin and
HealthPartners Oncology/Hematology Program.
Park Nicollet Frauenshuh cancer center | 2014 annual report
7
2014 screening and prevention results
Skin Cancer Screening
In honor of Melanoma/Skin Cancer Detection and Prevention Month, Park Nicollet hosted its free skin
cancer screening event at the Frauenshuh Cancer Center on May 17, 2014. “Demand was off the charts,
with 103 people coming in to be screened.” said Larisa Speetzen, MD, a Park Nicollet dermatologist who
donated her time at the event. “That’s encouraging because it means the public is getting the message that
prevention is key.”
Melanoma of the skin is the most common type of cancer in the United States, with nearly 1,500 new cases
reported last year in Minnesota. Twenty-eight team members from Park Nicollet dermatology and the
Frauenshuh Cancer Center donated a total of 100 volunteer hours to the screening event.
Be Pink and Breast Cancer Awareness Month
Cancer researchers know that about one in eight U.S. women (about 12 percent) will
develop invasive breast cancer over the course of a lifetime. Death rates for breast
cancer have been decreasing since 1989. This is especially true for women under age 50.
These decreases are thought to be the result of treatment advances, earlier detection
through screening and increased awareness.
In partnership with Park Nicollet Foundation, Park Nicollet’s Jane Brattain Breast Center continues its
Be Pink initiative to support and promote breast health, early screening and breast cancer detection for
women in the Twin Cities. Because of a strong Be Pink campaign in October, screening mammography
volumes increased by 10 percent that month. Diagnostic
screenings increased more than 25 percent. The Mammoa-go-go mobile mammography testing unit also noted an
increase in use during the campaign.
Park Nicollet Jane Brattain Breast Center was the
presenting sponsor of local radio station KS95’s Team
Moon & Staci for Race for the Cure on Mother’s Day.
Our sponsorship was promoted during on-air spots
and also had a digital presence – with website banner
announcements, a custom microsite (mini website) and
social media postings.
The center had a prominent booth at the race and
provided breast cancer materials. In total, the effort
delivered approximately three million impressions.
8
Park Nicollet Frauenshuh cancer center | 2014 annual report
We find ways to
improve our patients’
overall quality of life as
they embark on their
cancer journeys.
MammoJam, Mill City Nights
Scotty McCreery with staff members
MammoJam was a successful benefit concert for the Jane Brattain
Breast Center held Oct. 29, 2014. Provided in partnership with CBS
Minnesota, the event featured performers Brett Eldredge, Scotty
McCreery, Swon Brothers and Thompson Square. Local businesses
supported the breast cancer awareness and Jane Brattain Breast
Center by lighting their downtown buildings in pink or by offering
promotional discounts. October outreach events included screenings,
health fairs and speaking engagements promoting early detection.
Team spotlight
Kathryn Moore, MD specializes in caring for adults with cancer and blood disorders.
She has a special interest in treating patients with breast and lung cancer. Dr. Moore
received her medical degree from Louisiana State University Health Sciences
Center. She completed an internal medicine residency and a fellowship in
hematology, oncology and stem cell transplantation at Rush University Medical
Center in Chicago. “Every day I am amazed and inspired by the courage, grace, and
perseverance that my patients possess. I enjoy working closely with patients and
their families to provide high-quality cancer care based on the latest medical
research. I also respect the fact that each patient is an individual and will have their own way of dealing
with their unique journey.”
Jessica Arneson joined the Frauenshuh Cancer Center in 2014 as the manager of
radiation oncology and the oncology site manager. She has a bachelor’s degree in
nuclear medicine from St. Mary’s University in Minnesota and has recently
completed her master’s degree in health care administration at the University of
Minnesota. Jessica joined the Park Nicollet nuclear medicine department in 2004.
She transitioned into nuclear cardiology as the non-invasive cardiovascular manager
in 2007.
Park Nicollet Frauenshuh cancer center | 2014 annual report
9
2014 awards and achievements
Lorre Ochs, MD, FACP-FACS, received the Touchstone Award at the St. Francis Regional Medical Center’s
gala in Oct. 2014. This award recognized Ochs for going above and beyond in the care she provides
patients, for actively partnering across the organization to improve care and for her leadership within
the St. Francis Cancer Center as well as her contributions to the community. Ochs also served as the
immediate past president of the Minnesota Society of Clinical Oncology.
Carol Ann Petersen, LICSW, MAHS, patient support and education manager, received the Helen Berg
Service Award, which honors team members who create an exceptionally caring experience for patients
and guests. The Helen Berg Service Award was established in 2009 and is named after a colleague who
lived and worked courageously with cancer for many years.
Yvonne Combs, RN, certified hospice and palliative care nurse, was honored for her exceptional care to
patients by receiving the Park Nicollet Methodist Hospital Nurse Excellence Award.
Nancy Gelle, nurse manager for hospice, palliative care and Growing Through Grief (a hospice program),
received the President’s Award from HealthPartners. This award recognizes colleagues who demonstrate
extraordinary efforts in providing outstanding care and service to HealthPartners members and patients.
Vicki Norton, RN, MHA, OCN, served as a director-at large for her fourth year to the Oncology Nursing
Society. ONS is a national organization with more than 35,000 members.
Susan Koering, MEd, RHIA, CTR, the oncology registry manager for Frauenshuh Cancer Center, served
a third year as chair of the National Cancer Registrars Association (NCRA) Education Foundation.
Chartered in 1974, the NCRA is a non-profit organization that represents more than 5,000 cancer registry
professionals and certified tumor registrars. Its mission is to serve as the premier education, credentialing,
and advocacy resource for cancer data professionals.
Mark Menge, MD, and Michael Haley, DO, served as members at large of the Minnesota Society of Clinical
Oncology. The organization promotes standards of excellence for high-quality cancer care.
A number of our team members served important roles with Metro Minnesota Nursing Society (ONS):
President: Norma Hocking, RN, OCN, President-elect: Nancy Anson, RN, OCN, Secretary: Jeanne
Harkness, RN, MSN, OCN, Treasurer: Cindy Jacobson, RN, OCN, Directors at Large: Adina Peck, NP,
AOCN; Cindy Ouimet, RN, OCN; Karen Miller, RN, OCN, Vicki Norton, MHA, RN, OCN, Government
Relations: Ann Deshler, RN, BSN, OCN, Membership Chair: Mary Mateffy, RN, OCN, Nominating Chair:
Betsy Koch, RN, OCN, Annual Conference Chair: Mary Ehresman, NP, AOCN
Three registered nurse team members received new Oncology Certified Nurse (OCN) credentials:
Barbara Sweeney, Melanie Schweizter, Lindsey Anderson
10
Park Nicollet Frauenshuh cancer center | 2014 annual report
Oncology registry
Most common cancer sites
The four most common cancers for Park Nicollet patients in 2014 (excluding skin cancers) were breast,
lung, prostate and colorectal. These four sites account for 44 percent of all cases, according to the
American Joint Committee on Cancer (AJCC).
In Minnesota, the most common cancers listed in order of occurrence as published in the American
Cancer Society’s “Cancer Facts and Figures 2014,” are prostate, breast, lung and colorectal. Table 2
compares Park Nicollet’s case totals with the estimated number of cancer cases in Minnesota and the
United States.
For these four cancer sites (and all cancers) early diagnosis and treatment are very important. The earlier
the stage at which these cancers are diagnosed and treated, the better the patients’ long-term prognosis
and survival.
Table 1: Four most common sites by AJCC stage
at Park Nicollet Health Services
Stage iii
Stage iv
Unknown
Unknown
Stage 0
24
14
4
3
0
Stage 0
Stage iv
Stage i
25
34
103
Stage ii
Table 2 compares, by site
and percentage, Park
Nicollet’s case totals with the
estimated number of cancer
cases in Minnesota and the
United States.
Stage iii
94
Table 2: Four Most
common Cancer sites
25
%
Stage i
Stage ii
229
92
8
Female Breast Cancer 2014
Prostate Cancer 2014
468 total cases
179 total cases
%
%
5
7
14
colorectal
8
13
prostate
Unknown
Stage 0
Unknown
Stage 0
3
2
5
1
8
13
Lung
Stage iv
Stage i
15
22
22
54
Stage iv
Stage iii
Stage ii
32
25
10
Stage i
Breast
85
13
14
Stage ii
Stage iii
12
26
Colorectal Cancer 2014
Lung Cancer 2014
99 total cases *
male=43, female=56
*carcinoids of the appendix not included
183 total cases
male=72, female=111
Park
nicollet
health
services
Minnesota
United
states
Park Nicollet Frauenshuh cancer center | 2014 annual report
11
Table 3: Park Nicollet Cancer Center Administrative Report 2014
* Analytic:
cases diagnosed
and/or having
initial therapy at
Park Nicollet
** Non-analytic:
cases having all
initial therapy
elsewhere, seen
at Park Nicollet
for further care
and treatment
Analytic cases*
Non-analytic cases**
Cases presented at tumor conferences (general, gynecologic, breast, lung)
Physicians attendance at conference
Radiation therapy patients (new)
Radiation therapy treatment fields
Outpatient IV therapy visits
Outpatient oncology/hematology clinic visits
New cancer admissions to hospice
New cancer admissions to home care
Percent of patients entered on protocols
2013
2118
64
546
1108
671
15,937
30,327
25,469
345
62
2014
2118
39
613
1215
662
16,201
30,764
27,050
337
94
7%
11%
Table 4: 2014 Cancer Cases Diagnosed by Tumor site and Gender
Breast
Skin
Lung
Prostate
Lymphoma
Colorectal
Bladder
Other/ill-defined
Uterus
Head and neck
Kidney
Leukemia
Endocrine
Pancreas
Nervous system
Ovary
Multiple myeloma
Other GI
Unknown primary
Stomach
Anus
Vulva
Testis
total
12
Park Nicollet Frauenshuh cancer center | 2014 annual report
total cases
473
22%
285
13%
183
9%
179
8%
105
5%
102
5%
89
4%
75
4%
73
3%
72
3%
64
3%
63
3%
53
3%
51
2%
48
2%
43
2%
33
2%
32
2%
24
1%
22
1%
19
1%
17
1%
13
1%
2,118
100%
5
167
72
179
59
47
56
31
0
48
39
31
22
34
24
0
21
19
12
15
8
0
13
902
male
1%
19%
8%
20%
7%
5%
6%
3%
0%
5%
5%
3%
2%
4%
3%
0%
2%
2%
1%
2%
1%
0%
1%
100%
female
468
38%
118
10%
11
9%
0
0%
46
4%
55
4%
33
3%
44
4%
73
6%
24
2%
25
2%
32
3%
31
2%
17
1%
24
2%
43
4%
12
1%
13
1%
12
1%
7
1%
11
1%
17
1%
0
0%
1,216 100%
Oncology research review
Finding treatments, cures depends on clinical trials
By Daniel M. Anderson, MD
Clinical trials remain a vital part of cancer treatment. Trials represent the final phase of cancer research,
in which new treatments are proven more effective or less toxic than existing therapies.
Most major groups that set guidelines for how to treat cancer, such as the National Comprehensive
Cancer Network, unequivocally state that the best care for any cancer patient is a well-designed clinical
trial. Despite these recommendations, only 3 to 5 percent of cancer patients in the United States are
treated on clinical trials. This is because some patients have concerns about enrollment in trials and not
wanting to be a “guinea pig.”
Through active patient education and shared decision making, HealthPartners Clinics and the
Frauenshuh Cancer Center at Park Nicollet (all a part of one organization now) have been highly
successful in enrolling cancer patients on clinical trials, earning commendation from accrediting bodies
such as the American College of Surgeons.
Despite our past successes, however, much remains to be done.
Oncology clinical trials typically originate by one of two ways: through the National Cancer Institute
(NCI) or through pharmaceutical companies (industry). In addition to having a strong culture of locally
developed research, HealthPartners and Park Nicollet have participated in NCI studies for more than 20
years as part of a local research collaborative called Metro Minnesota Community Oncology Research
Consortium. HealthPartners and Frauenshuh Cancer Center have been active in offering the latest
cutting-edge research from the NCI to our patients. Our physicians have also maintained leadership
roles in the development and implementation of clinical trials at both the national and local level.
HealthPartners and the Frauenshuh Cancer Center also participate in trials sponsored by the
pharmaceutical industry, offering our patients a wide variety of clinical trial options. More than 75 NCI
and industry clinical trials are currently available at our clinics for patients with most types and stages
of cancer.
Because funding for the NCI continues to decline, more studies are sponsored by pharmaceutical
companies. HealthPartners and Park Nicollet physicians complete a thorough review process to ensure
that only the most scientifically sound, industry-funded trials are available to our patients. The trials we
offer allow patients to receive innovative cancer treatment close to their homes, sparing them longdistance travel to receive treatment.
Park Nicollet Frauenshuh cancer center | 2014 annual report
13
Judy Dougherty is a patient who has clearly benefitted from
enrollment in a clinical trial. In 2006, at age 46, she was diagnosed
with metastatic breast cancer, a typically fatal disease. Judy
elected to enroll in an early phase clinical trial at Regions Hospital
studying an investigational agent for breast cancer. She received
chemotherapy for more than one year, during which time her
disease went into complete remission. She has remained in a
complete remission since her diagnosis and has seen her four
daughters accomplish many milestones that she never expected
when first diagnosed. Judy recognizes the benefits she received
from her participation in a clinical trial and has become a strong
proponent of oncology trials.
Regions Hospital, HealthPartners Clinic-Riverside and Park
Nicollet Clinic have continued a tradition of research excellence in
2014 and 2015. Some of the highlights:
• Regions Hospital and Riverside Clinic had the highest overall NCI
treatment accrual in the Twin Cities.
Only the most
scientifically
sound, industryfunded trials are
available to our
patients.
• Park Nicollet Frauenshuh Cancer Center had the highest overall NCI treatment accrual per investigator.
• Regions Hospital and the Frauenshuh Cancer Center were two of only a handful of sites selected to
participate in a trial of early palliative care in lung cancer patients.
• The Metro Minnesota Community Oncology Research Consortium (headquartered at Park Nicollet)
remained one of the strongest community-based research entities in the country, with the highest
accrual in the country to multiple important NCI and industry studies. It continues to receive substantial
NCI grant funding as recognition of its national prominence.
• Richard Peterson, MD, was elected to serve on the NCI brain malignancy steering committee and will be
directly involved with the design of new trials for brain cancer.
• Balkrishna Jahagirdar, MD, continued to serve on the novel therapeutics committee for the Alliance for
Clinical Trials in Oncology. He also serves as a community study chair for a trial in thyroid cancer.
14
Park Nicollet Frauenshuh cancer center | 2014 annual report
• Dylan Zylla, MD, serves as the cancer care and delivery research principal investigator for the Metro
Minnesota Community Oncology Research Consortium. He also participates as the local principal
investigator for several pharmaceutical treatment trials.
• Rachel Lerner, MD, serves as the local principal investigator for several pharmaceutical studies and is
part of the review committee to ensure trials open at Frauenshuh Cancer Center and HealthPartners
Clinics meet appropriate standards.
• I serve on the Board of Directors for the Alliance for Clinical Trials in Oncology. I also serve on the
leadership team for the Metro Minnesota Community Oncology Research Consortium.
Looking forward to 2016, there are several exciting studies on the horizon. We are in the process of
opening a large study investigating whether palbociclib, a nontoxic targeted agent shown to help women
with widespread breast cancer, can improve cure rates in women with earlier stage disease. We also hope
to open multiple studies examining innovative immune-based therapies for lung cancer.
As our understanding of the biology of cancer improves, our treatments will continue to become more
effective and less toxic. We at HealthPartners and Frauenshuh Cancer Center remain firmly committed
to clinical trials and will continue to offer cutting edge treatments to our patients.
Daniel M. Anderson, MD
Medical oncologist and co-medical director of
oncology research
Park Nicollet Frauenshuh Cancer Center
Daniel M. Anderson, MD, is a board certified hematologist-oncologist and a member of the faculty of the University of Minnesota
Department of Hematology, Oncology and Transplantation. After
graduating from St. Olaf College, he received his medical degree and
master’s degree in public health from the University of Minnesota.
Dr. Anderson completed his internal medicine training at Hennepin
County Medical Center and a hematology/oncology fellowship at the
University of Minnesota. He has completed special training in clinical
cancer research and has a special interest in studying therapies for
advanced cancer.
Park Nicollet Frauenshuh cancer center | 2014 annual report
15
Oncology research review
Research on cancer pain and symptom management
By Dylan Zylla, MD
As a medical oncologist and co-medical director of oncology research at Park Nicollet, I strive to find
ways to improve our patients’ overall quality of life as they embark on their cancer journeys. My specific
research focus is on relieving cancer pain and other burdensome symptoms such as nausea, diarrhea,
fatigue and depression.
Pain is a particularly challenging problem that affects the majority of patients diagnosed with cancer. Two
out of every three patients with advanced cancer experience pain, with nearly 50 percent experiencing
moderate to severe levels of pain.
My research in cancer pain and symptom management began at the University of Minnesota during my
fellowship training and has since led to numerous projects at Park Nicollet.
Examples of these projects:
• Zylla D, et al. Opioid requirement, opioid receptor expression, and clinical outcomes in patients with
advanced prostate cancer. Cancer (2013)
• Zylla D, et al. Association of opioid requirement and cancer pain with survival in advanced non-small cell
lung cancer. Br. J. Anaesth. (2014)
• Zylla D, et al. Pain score, analgesic utilization, and patient satisfaction among cancer patients at a
community cancer center. Presented at ASCO Palliative Care Symposium (2014)
As a recipient of a National Institutes of Health Research training grant, I was given the opportunity to
expand my clinical research skills through a master’s degree program in clinical research. I completed two
projects on the role of cancer pain and opioid utilization and how each may impact survival in patients with
advanced malignancy. Both led to publications in well-respected medical journals.
We became the first group to demonstrate shorter survival in patients with metastatic prostate cancer who
had high opioid use to control pain. Later projects expanded on our early work and examined the complex
role of pain and opioid use in patients with advanced non-small cell lung cancer. We again showed that both
high levels of opioid use and high levels of pain were associated with shorter survival.
16
Park Nicollet Frauenshuh cancer center | 2014 annual report
Obtaining better control of cancer pain, while
limiting any untoward effects of opioids, is of
utmost importance to our patients. With this in
mind, I led a quality improvement project focused
on improving cancer pain management at Park
Nicollet Frauenshuh Cancer Center. I created a
workgroup that included a palliative care physician,
a pharmacist, a quality improvement director, an
oncology nurse practitioner and an oncology nursing
supervisor. Based on cutting-edge pain research, we
implemented a clinic policy of asking all patients about
their personal pain goals. We found patients
at Frauenshuh Cancer Center achieve their personal
pain goal more than 90 percent of the time. Our
findings were presented at the inaugural American
Society of Clinical Oncology (ASCO) Palliative Care in
Oncology Symposium.
Current projects:
• Zylla D, et al. Impact of opioid use on survival
in patients with newly diagnosed stage IV
non-hematologic malignancies. Accepted for
presentation at ASCO Palliative Care Symposium
(2015)
• Phase 3 randomized trial of a medical cannabis
product (nabiximols/Sativex) in patients with
advanced cancer pain. 2013-2015 (Principal
Investigator – Dylan Zylla, MD)
Music therapists and course signs from Marathons of Hope
• Incorporating patient-reported outcomes in symptom management with ASCO Palliative Care Virtual
Learning Collaborative. 2014-2015 (Team leader – Dylan Zylla, MD)
Studies show patients with better quality of life have improved survival regardless of treatments
administered. Recent reports demonstrate early palliative care intervention benefits both quality of
life and survival in patients with advanced lung cancer. The ASCO now promotes earlier integration of
palliative care services into standard oncology care.
Park Nicollet Frauenshuh cancer center | 2014 annual report
17
Frauenshuh Cancer Center was selected as one of 20 cancer centers throughout the country to participate
in a new online learning collaborative sponsored by ASCO as a way to improve our delivery of palliative
care interventions to patients. Through this partnership, we began a palliative care training program for
our nurse practitioners and physician assistants as a way to ensure that all our patients have access to the
best symptom management knowledge available. We also began a clinic-wide effort to implement patientreported surveys on tablet computers upon clinic check-in to help us assess and adapt to the most pressing
symptoms that patients report.
The medical cannabis program through the Minnesota Department of Health started in July 2015.
However, our experience with medical cannabis began in 2013 when I served as the principal investigator
for an industry-sponsored trial of a synthetic medical cannabis drug called nabiximols (trade name
Sativex) for cancer patients with severe pain. Several patients at Park Nicollet Frauenshuh Cancer Center
participated in this trial, and all tolerated the drug well with little side effects. We are awaiting results of
this trial to determine how well nabiximols controlled pain compared to a placebo. Aside from prior studies
with nabiximols, there is very little scientific data showing clear benefits of medical cannabis. As such, we
are working to find ways to study the role of medical cannabis as it pertains to cancer pain and symptom
management. We hope to highlight both the potential benefits and harms by use of medical cannabis.
Future research proposals:
Park Nicollet is
a leader in the
field of pain
and symptom
management.
18
Through a grant from the Park Nicollet Institute we will soon
implement a new electronic check-in system for our cancer patients
using tablet computers that link directly with the electronic health
record. This technology will allow us to monitor and treat symptoms
quickly and track outcomes for all patients under our care. Numerous
quality improvement projects will be easily completed once this
registry is created. One project currently in development aims to
closely track pain and nausea in patients who use medical cannabis.
Results of this project have the potential to shape decisions on use
of medical cannabis both locally and nationally, and will help to
demonstrate that Park Nicollet is a leader in the field of pain and
symptom management. Future grant and philanthropic support will
help us create a Cancer Pain and Symptom Management Center. This
would help Park Nicollet become a national leader as we continue our
pledge to provide the best cancer care with the best quality of life.
Park Nicollet Frauenshuh cancer center | 2014 annual report
Dylan Zylla, MD
Medical oncologist and co-medical director of
oncology research
Park Nicollet Frauenshuh Cancer Center
Dr. Zylla with project colleague and research nurse
Nancy Nixon
As a medical oncologist and hematologist, Dylan Zylla,
MD, values the relationships he develops with patients who
have cancer or blood disorders. “I strive to provide clear
explanations of complex and often frightening diagnoses and
support both patients and their families with the compassion
they deserve. My goal is to provide quality, evidence-based
medicine that maximizes the opportunity to combat disease,
while also preserving one’s quality of life. My research
interest is to determine how the control of cancer pain
may improve clinical outcomes, specifically in patients with
cancer of the breast, lung, prostate and colon. I utilize skills
from my master’s degree in clinical research to coordinate
clinical trials that I hope will improve patient care, relieve
suffering, and help advance our understanding of cancer.”
Dr. Zylla received his medical degree from the University of Minnesota where he completed his residency
and hematology/oncology fellowship. He also holds a master’s degree in clinical research from the
University of Minnesota’s School of Public Health.
Park Nicollet Frauenshuh cancer center | 2014 annual report
19
Oncology research review
Clinical trials are essential to making advances in cancer treatments for patients by systematically
evaluating the effectiveness of new treatments or interventions. Our Oncology Research Program offers
access to state-of-the-art trial options for patients undergoing cancer treatments. We also conduct a wide
variety of studies focused on cancer prevention and symptom management for patients undergoing cancer
treatments, and studies to help us understand the biology of cancer. Our mission is to improve the survival
and quality of life of those we serve.
We have an expert research staff with many years of experience in clinical research. Park Nicollet patients
also have access to clinical trials sponsored by the National Cancer Institute through the Metro-Minnesota
Community Clinical Oncology Program (CCOP).
Oncology research highlights
• One hundred eighty-eight patients of Park Nicollet Frauenshuh Cancer Center were enrolled in clinical
trials during 2014. This constitutes 8.8 percent of all oncology patients diagnosed at Park Nicollet. Eight
new studies were initiated in 2014.
• Through the ENACCT program, a collaboration between CCOP and Park Nicollet Oncology Research
Program, we were able to increase accrual for early stage breast cancer patients to treatment trials from
0.5 percent (at the end of 2013) to 4 percent in 2014.
• Park Nicollet was the top-enrolling site for NCI trials in the Metro-MN CCOP consortium.
• To carry out our research effort, Park Nicollet hired a new research nurse, Cindy Ouimet, and a research
assistant, Kris Vukelich.
• Productive meetings have been held to discuss the future direction and support for merging Park Nicollet
and HealthPartners oncology research. Ann Deshler, practice research consultant, has been instrumental
in working with organization leaders to explore operational changes that need to be addressed before
our oncology research program can enroll patients at HealthPartners cancer clinics.
Grants/Projects
2014 Shoulak BreastFest Fundraiser awarded a grant to support nutrition research at Frauenshuh Cancer
Center. Principal investigator for our nutrition research is Alice Shapiro.
Park Nicollet Foundation awarded five grants to the Frauenshuh Cancer Center Research through
various funds:
• “A retrospective assessment of patient-reported pain levels, opiods prescribes and survival at FRCC,”
Principal investigator: Dylan Zylla.
• “Effect of introduction dialogues on acceptance of music therapy in a community cancer center,”
Principal investigator: Leanne Barck.
20
Park Nicollet Frauenshuh cancer center | 2014 annual report
(L to R): Cindy Ouimet, RN, research nurse; Nancy Nixon, RN, MMCORC, research nurse; Jessica Miller, BA, CCRP, MMCORC, cancer
control coordinator; Laura Maybon, RN, manager, oncology research; Jamie Edenborg, MMCORC, research coordinator; Jori Lovdahl,
RN, MMCORC, research nurse
• “A quality improvement project to assess the impact of the use of scribes in the Frauenshuh Cancer
Center,” Principal investigator: Rachel Lerner.
• “Providing breast cancer survivorship: lessons learned from a pilot project implementation,” Coinvestigators: Kathleen Johnson and Rachel Lerner.
• Oncology Research Project to assess patients for “Clinical Trial Awareness and Research Participation,”
Investigators: Alissa Gavenda, Laura Rockwell, Amber Egan.
Manuscripts published
Zylla D, Kushowski MA, Gupta K, Gupta P. Association of opioid requirement and cancer pain with survival
in advanced non-small cell lung cancer. Br. J. Anaesth. (2014) 113 (suppl 1): i109-i116
Halcon L, Lillehei A, Melin M, Shapiro A, Robinson C. Wound Care: Multi-center Feasibility Study. Adv in
Skin and Wound Care Accepted for publication May 2014.
Abstracts/Posters/Presentations
Abstract and Poster: Robien K, Kirstein M, Shapiro A. Pilot Study to Determine BPA Exposures among
Women Receiving Aromatase Inhibitors (Sub study of the NIH Grant D3AI)
Gordon Research Conference on Environmental Endocrine Disruptors, Lucca (Barga), Italy, May 2014
Abstract and Poster: Zylla D, Van Peursem S, Illig L, Peck A, Pawloski, P, Fulbright J, Richter S, Larson A.
Pain scores, analgesic utilization, and overall satisfaction among cancer patients: a quality improvement
project. Palliative Care in Oncology Symposium: Patient Centered Care across the Cancer Continuum,
Boston, Mass., October 2014
Abstract and Poster: Zylla D, Kuskowski M, Gupta K, Gupta P. Association of opioid requirement and
cancer pain with survival in advanced non-small cell lung cancer. Palliative Care in Oncology Symposium:
Patient Centered Care across the Cancer Continuum, Boston, Mass., October 2014
Oncology Research Staff (Shapiro A, Gavenda A, Deshler A, Coles C) presented an update on oncology
research at Nursing Grand Rounds for all nurses at Park Nicollet Health Services. October 2014
Dylan Zylla, MD, presented “Improving pain management in patients with cancer – a quality improvement
project” to leadership of Park Nicollet/HealthPartners
Park Nicollet Frauenshuh cancer center | 2014 annual report
21
2014 annual gifts to
Frauenshuh Cancer Center and
Jane Brattain Breast Center
$50,000 Plus LaMoine J. Flaig
David and Sandra Frauenshuh
HealthPartners
$25,000 Plus
Curtis L. Carlson Family Foundation
$10,000 Plus
Robert Haselow, MD and Justine Haselow
William A. Hodder
Hope Chest for Breast Cancer Foundation
The Janice Gardner Foundation
Mark Z. Jones, II and Judie Jones
Gary and Loranne Lindstrom
Schuler Shoes
$5,000 Plus
Don and Jane Brattain
Frauenshuh, Inc.
Michael Haley and Jacqueline Chandonnet
Wayne and Carol Jorgenson
Bill and Gail Munsell
Riverwood National Breast Cancer Tournament
Wayne T. Spears, MD
22
Park Nicollet Frauenshuh cancer center | 2014 annual report
Through Park
Nicollet Foundation,
generous donors
are able to support
Park Nicollet
Frauenshuh Cancer
Center’s patients
and families through
the physical and
emotional journey
from treatment to
survivorship.
$1,000 Plus
Anchor Bank of Wayzata
Michael Anderson
Anonymous
Patricia Bailey
Darrell E. Catton
Checker Distributors
Cathleen Chen, MD
City of Wayzata
Consolidated Communications
Harris and Darcy Cooper
Earl Holasek & Son
Greenhouses, Inc.
Martha J. Erickson
David and Renee Ethier
Catherine L. Fischer
Robert A. Green, MD and
Ellen Green, MD
Darrel and Karen Hamann
Lucinda L. Hartmann
Frederick and Sharon Hegele
Laura and James Holasek
Jeffrey B. Husband, MD and
Mary E. Husband
George C. and Dr. Judith A.
Klimkiewicz
Brenda R. Larson, MD
Joel Lebewitz
Richard C. Lidbom
Lurie Besikof Lapidus &
Company, LLP
Douglas B. Malchow
Robert and Sandra Mariotti
Mark Menge, MD and JinJer
Menge
Mauritz and Alice Mortenson
Susan M. Muench
New Reflections of Hair Design
Inc
Amy G. Novogratz
Amy Post
Nickolas and Judith Priadka
Robert Randall
Christine A. Rittmann
Lisa J. Schmidt
Susan B. Schmidt
Duane and Susan Spiegle
Richard and Claudia Swager
Kenneth and Janet Thome
The Walser Foundation
Angela Weber
Judith Kilian Weber and Jeffrey
Weber
Milly and John Whittington
Liz Wynne
Dylan Zylla, MD and Emily Zylla
$500 Plus
Mr. and Mrs. Dale Bachman
Christina Boyd
Mr. and Mrs. Robert E. Buuck
Peter and Dianne Cook
Domenic D’Arrigo
J. Timothy Diegel, MD and
Colette Diegel
Doran Construction Company,
LLC
Education Minnesota Edina
Jason and Tracy Eickhoff
Ken Fischer
Robert and Julie Flaschenriem
Richard and Suzanne Geise
Charlotte Gjersdal
Vicki and Dave Glenn
Scott L. Glickstein, MD and
Sydney Kase
Jon and Linda Gross
Warren K. Hall
Pamela S. Hargrove
David E. Hoops, MD and Karen
Hoops
Donald R. Johnson
Jeff Kimpton
Joan Larson
John Lorentz
Kristi A. Lyon
Steve and Sharon Maidment
Debra L. McGovern
Dominique and Susan Najjar
Sharon M. Ochocki
Linda Odegard and
Harlen Cavert
Dawn Ohnstad
Dave and Mary Osgood
Chuck and Wendy Ott
James and Donna Peter
Paul and Kimberly Roach
Scott Ross, MD and
Dr. Angela Ross
Robert D. Shadley
William Shimp, MD and
Mitzi Shimp
Amy B. Spomer, MD
Ted H. Spooner, MD
Thomas Stillman, MD and Liba
Stillman
William and Pam Telleen
The Hourglass Fund Project
Norna Therrien
Thomson Reuters
Thomas and Deborah
Vanderheyden
Mark Wilkowske, MD and
Kristin Wilkowske
Mervin and Gerri Winston
$100 Plus
Aafedt, Forde, Gray, Monson
& Hager
David J. Abelson, MD and
Susan Abelson
Lauren M. Adams
Kristin L. Aleman
Jack and Cheryl Amdal
Barb Anderson
Carly Anderson
Derek Anderson
Mary C. Anderson
Ray and Marilyn Anderson
Gregory and Ann Anklam
Anonymous
Mick Anselmo
Nicholas J. Armstrong
Jessica Arneson
Philip Asgian
Merlin Athmann
Deanna Au
Julie B. Bachman
Nancy A. Baker
Judith L. Bari
Regina A. S. Barr
Christine Barry
Shirley and William Baxter
Beacon Bank
Gardell and Christine Bearl
Daniel and Emily Becker
John A. Becker
Lori C. Belz
Christopher and Beth Berg
Park Nicollet Frauenshuh cancer center | 2014 annual report
23
Mark Menge, MD
Richard Bergenstal, MD and
Carol Bergenstal
Nicole Bergeron
Jaime Besser
Marilyn Bierden
Clarence C. Birkhauser
Valerie M. Blanchett
James and Eileen Blasko
William Blazar and
Mary Hunstiger
Brian Bojan
Donald B. Bonstrom
Leslie and Lezlie Bork
Priscilla Brewster
Blyth B. Brookman
Brown & Carlson, PA
James and Lori Brown
Mary K. Brusegard
Brenda and Jeff Brustad
Kathleen Bryant and
Jonathan Lindfors
Marilyn T. Bryant
Elizabeth M. Bulleigh
Andrew and Kenzie Burback
Thomas and Theresa Burke
Maureen and Robert Burns
Jason R. Bysina
Sue Calhoun
Nancy Campbell
Karen R. Carlsen
Gayle Carlson
Barbara A. Carmouche
Angela Carpenter
Kerry Carroll
Joel Carter
Robert and Mary Cecconi
Celonics, Inc.
Elise Chambers
Judy and Bill Cherne
Elizabeth B. Cherne
David Ching and
Lee Bastyr Ching
24
Park Nicollet Frauenshuh cancer center | 2014 annual report
Jeanne M. Clarke
Richard Colletti
Cheryl R. Cooper
Emmett and Patricia Costello
Covenant Village of
Golden Valley
Ralph E. Craner
Kristina Cummings
Kenneth and Betty Dahlberg
Krista and Michael Danner
Ms. and Mr. Belle C. Davenport
Elizabeth Davies
Harriett Dayton
Rachel and Andrew DeMaster
Michael J. Dempsey
Caitlin DeVos
Nancy Dickinson
Sandra G. Dignen
DMurray Real Estate LLC
Karen Donald
Larry Dow
Michael and Susan Dubbs
Daniel Dudon
Donald A. Duncan, MD
Mary Beth and Kent Dunham
Debra and Michael Dwyer
Kelley Catton Dwyer and
Patrick Dwyer
Dianna J. Eastlick
Leone and Robert Eidsmoe
Jim Elfering
Cynthia B. Ellefson
Richard Elsberry
Barbara L. Skoog
Anonymous Employee
Paul and Wendy Engelman
Lori and Daniel Enger
Brian E. and Karen L. Evans
Excelsior Brewing Company, LLC
Joan Fenton
Martha Fischer and\ Bill Lutes
Niki Flavin
Deborah F. Fleetham
Peter O. Flom
Marlene Fondrick
Lawrence and Kathleen Fosbury
Frauenshuh Commercial Real
Estate Group
Darcy Frischholz
Kelly S. Furda, MD
Dale and Stacy Gallion
Richard and Ann Garland
Milton and Mary Jane Geiser
Chris and Christa Getchell
Geri Ginder
Henry and Charlotte Gjersdal
Darci Gjerstad
Stanley M. Goldberg, MD and
Luella Goldberg
Howard A. Goldfine
A. Nancy Goldstein
Joseph and Patricia Grabowski
Michelle and Richard Griffith
Robert P. Gruninger
Bruce Grussing
Jane H. Gueldner
Eva Gutmann
H & K Enterprises L.L.C.
Genevieve Hafner
Jane D. Hall
Jacob Hallen
Margaret Hanson
Megan Hanson
Jeanne M. Harkness
Ann and Daniel Harris
Konnie K. Harstad
John and Linda Hayes
HealthSource of Minnetonka
Mark and Mary Jo Heieren
Robert and Sally Helmerichs
Sue Hemmeke
Joyce and Thomas Henderson
Russell Henriksen
Marnie and Carl Hensel
Sharon M. Hepler, MD
Mr. and Mrs. Ken Higgins
William Higgins
Marathons of Hope participants
Mikaila R. and Ryan K. Hinman
Norma J. Hocking
Gina Holman
John and Judith Holscher
Jean M. Holten
Sheri L. Honn
Kathleen and Peter Huch
Annie R. Huidekoper
David B. Hydukovich
IBM Employee Services Center
Grace and John Iverson
Carol A. Jackson
David C. Jackson
Mary Lou Jackson
Linda and Douglas Jaeger
Delores A. Jensen
Deloris E. Jensen
Patricia A. Jenson
Michael Jesse
Amanda Johnson
Bette Johnson
Dayle and Meryl Johnson
Thomas A. Jones, MD and
Anne F. Jones
Sandra and Michael Kamla
Faye and Jeff Kamrath
Donna and Owen Kane
Dr. Mary Jo Kane
Roxy Katchmark
Ida Kats
Lois H. Kelly
Kim Kelsey
Sarah L. Kelsey
Alcuin F. Kilian
Ann Knuti
Elizabeth and Timothy Koch
David and Mary Beth Koehler
Susan M. Koering
Stephen and Mary Kosel
Magdalene Koumas
Robert and Kris Kovalik
Douglas Kratz
Nicole Krolikowski
Roger Krueger
Bradley and Melissa Krump
John and Susan Kueck
Joe G. Kuehn
Lynn Kuehn
Arthur and Cathy LaPoint
Amber R. Larson
Robert and Carolyn Laskey
Jan Laudenbach
John J. Laurich
Louise Lehner
Deanna and David Leivestad
Peter and Catherine Lenagh
Carol J. Lentz
Norma Leonard
Dana S. Levinson
Mr. and Mrs. Brad S. Lewis
Patricia and Michael Lieppman
Dr. Regina M. Light
Dorothy A. Lillestrand
Holly E. Lund
Rhonda and Dave Lundgren
Gina Macleod
Deborah and Brian Madson
Anne T. Maimares
Mairs and Power, Inc.
Jeff and Camie Mayer
Mr. and Mrs. Donald W.
McCarthy
Edwin McCarthy
Anne McClintock
Jessie McClintock Kelly
Kitty McClintock
Timothy McCormick
Karen K. McMahon
Adina Peck, ANP, GNP
Megan and A. Douglas McNicoll
Cara and John McNulty
Medtronic Foundation
Methodist Hospital Hospice and
Oncology, Inpatient
Jodi Michaels
Elizabeth Miller
Katherine L. Miller
Minnesota Chamber Foundation
Jerry Mithuen
Steven E. Mithuen
Maria Moran
Jayne Morrison
Corrie Muench
Diane R. Nagengast
Michelle and Umit Nasifoglu
Naughton Insurance, Inc.
Cheryl Nelson
Gunnar Nelson
New Hope Women of Today
Kristine L. Newcomer
Heidi Nichols
Nina Nikpour
Rebecca E. Nyguard
Carolyn Oakman
Sandy Olevitch
Gloria Olsen
Mark and Jodi Olson
Lance Olson and
Ann Herzog Olson
Micaela Olson
Patricia Orsini
David L. Osthus
Heather Page
Janice E. Palkowski
Kari Palmer
Park Tavern
Jeffrey and Jean Parupsky
Barb Pass
Benjamin Pease, MD and
Kathleen Pease
Karyn Penn
Pets Remembered
Philkot, Inc.
Becky Pierson
Dorothy Ploucher
Susan Potter
Walter and Harriet Pratt
James Preisen
Phil Price
Jennifer and John Prichard
Nanette K. Quade
Terese Radford
Sunny Ray
Erika Remillard
Kristine H. Rich
Elizabeth M. Ringer
Michael J. Risvold
Sandra and John Robertson
Robins Kaplan Miller & Ciresi
Chris and Kelly Roe
Mr. and Mrs. Jeffry D. Roseland
Jeanne Rosengren
Percy and Annie Ross
Chris and Stan Rud
Dureen Ruff
Elizabeth Rutyna
Mark and Pamela Rutyna
James and Dianne Safley
Frank and Rebecca Sago
Rebecca J. Sago
Steve and Karen Sanger
Mark Satz, MD and
Gail Bender, MD
Shelly Scallon
Diane M. Scherber
Edward and Kathleen
Schoenecker
Arvid and Lillian Schroeder
Hope Schroeppel
Lisa M. Schuett
Park Nicollet Frauenshuh cancer center | 2014 annual report
25
Dennis and Pamela Schulstad
Linda L. Seaton
Robert and Vicki Semsch
Richard W. Setter
Pat and Sheron Sheehan
Melissa Sherman, MD
Alton C. Shimp
Judith Schoulak
Shumaker, Loop & Kendrick, LLP
Wallace and Rose Simpson
Brian and Pamela Sjoquist
Emery Skoog
Karen L. Skoog
Nancy Slaughter
Michael and Kathryne Slavics
Lynda and Brad Sleeper
Kathy Slowter
Juli A. Smith
Bridget Smith Coppes
Cory Soltis
Jeffrey and Carol Sorum
Brett Spark
Mary Spengler
John and Laura Spensley
Michelle M. Spielmann
Melanie and Jason Spry
Mary Grace St. Claire
Ashley Stoffel
Ralph Stoffel
Robert and Mavis Straughn
David G. Svendsen
Gretchen and Wayne Swenson
Katherine C. Tarvestad
Marilyn Taylor
TCI Business Capital
Dr. Byron and Karen Teska
Sandra Thoele
Angela K. Thompson
Peter Thomson
Timothy D. Thorpe
William A. Thurwachter
Robert Tjornhom
Arthur Tobkin
Tol O Matic
Ann K. Townsend
Travel Leaders/Market Square
Travel
Lindsay Triemert
Barb Tverberg
Robert and Helen Two Bulls
Thomas and Judy Tyler
U.S. Bancorp Foundation
Employee Matching Gift
Program
Don Uram
Robert C. Urban
Marlene and Bill Van Hecke
Hope Villanueva
Edward V. Violante, MD and
Elizabeth Violante
Melissa Warhol
Rene and Robert Warhol
Peter and Tricia Warns
Harold and Margaret Ellen
Watkins
Robie and Kris Wayne
James and Ruth Weaver
Robert and Jean Weiss
Kathleen and Lawrence Welliver
Bill and Mikell Werder
Nicolas and Sharon Westman
Sarah E. Wiczek
Mayor Ken Willcox
Winifred O. Willcox
Stacey and Daniel Willman
Adam N. Wilson
Ned and Christine Windmiller
The Wine Company
Bonnie L Wittenburg and Steven
Suppan
Michele and George Wittler
The Women’s Club of St. Louis
Park
Jodi Woodruff
Elizabeth Wright
Marynia S. Wronski
Oswald and Jane Wyatt
Dr. Tresa Zielinski
Christine Zohheveld
Cancer committee
The cancer committee meets quarterly at the Frauenshuh Cancer Center.
Mark Wilkowske, MD
Oncology
Chairman
Keith Heaton, MD
General Surgery,
Surgical Oncology (Cancer
Liaison Fellow/American
College of Surgeons)
Robert Haselow, MD
Radiation Oncology
26
Park Nicollet Frauenshuh cancer center | 2014 annual report
Steven Oncay, MD
Diagnostic Radiology
Kelly Furda, MD
JBBC
Matt McCoy, MD
Pathology
Howard Haines, MD
Emergency Medicine
Peter Argenta, MD
Gynecology Oncology
Whitney Evavold, MD
Hospitalist
Jocelyn Rieder, MD
Urology
David Willis, MD
Surgery, Colon & Rectal
Michael Miovic, MD
Psychosocial Services
give today!
Be a part of giving patients with cancer and their families hope, possibility and the tools
they need to thrive.
By check: Park Nicollet Foundation
6500 Excelsior Boulevard
St. Louis Park, MN 55426
Please include a note to let us know how you want your gift designated.
Online: www.parknicollet.com/SpecialtyCenters/Frauenshuh-Cancer-Center/Giving
Other: Please contact us at 952-993-5023 or [email protected] if you wish to make a gift
of stock, a gift through endowment or other types of gifts.
At Park Nicollet Foundation, we use philanthropy to enhance the patient and family experience,
promote innovation and research and respond to the health care needs of our community.
Gifts to Park Nicollet Foundation are tax-deductible to the full extent allowed by law.
Volunteering is also a way to make a difference in the lives of patients and their families. To learn about
becoming a volunteer in our cancer programs, please call 952-993-5086.
Cancer committee Ex-officio members
Jim Ferguson
Chaplain, Cancer Center
Nan Quade, RN, BHS, OCN
Park Nicollet Office Practice
Jennifer Grant
American Cancer Society
Susan Koering, RHIA, CTR
Oncology Registry
Emily Schoh, RN
Nursing 4E
Megan Hanson MS, CGC
Genetics
Vicki Norton, MHA, RN, ONS
Bryan Schuler, Pharm D, BCOP
Pharmacy
Christian Loger
JBBC
Nancy Gelle, BSN, RN
Palliative Care/Home Care/
Hospice
Paul Spilde, PT
Rehabilitation Services
Gladys Chuy
Quality Improvement
Laura Holasek
Administrative Director
Jessica Arneson
Radiation Therapy
Laura Maybon, RN
Oncology Research
Carol Ann Petersen, LICSW,
MAHS
Patient Support and Education
Park Nicollet Frauenshuh cancer center | 2014 annual report
27
3921 Louisiana Ave S
St. Louis Park MN 55426
952-933-3248
parknicollet.com/cancer